» Articles » PMID: 39287887

Radioimaging Foam Cells Infiltrating Atherosclerotic Plaques in Mice Using I-labeled OxLDL As a Radiotracer

Overview
Publisher Springer
Date 2024 Sep 17
PMID 39287887
Authors
Affiliations
Soon will be listed here.
Abstract

Bioimaging such as magnetic resonance is used to monitor atherosclerotic plaques consisting of foam cells, which are derived from macrophages that have ingested oxidized low-density lipoprotein (oxLDL). However, the current bioimaging techniques are not highly specific and sensitive in detecting foam cells, calling for the development of higher precision foam cell detection probes. Here, we investigated the utility of iodine-125-labeled oxLDL (I-oxLDL) as a prototype radiotracer in the radioimaging of foam cells infiltrating atherosclerotic plaques. Mouse bone marrow-derived macrophages (BMDMs) were used to analyze oxLDL uptake. Atherosclerosis mouse model was injected with I-oxLDL and DiI-labeled oxLDL (DiI-oxLDL). Accumulation of I-oxLDL and DiI-oxLDL in foam cells infiltrating atherosclerotic plaques was examined using Oil Red O (ORO) staining, autoradiography, and fluorescent immunohistochemistry. BMDMs phagocytosed oxLDL/I-oxLDL via CD36, but not LDL/I-LDL. The radioactive signal from I-oxLDL phagocytosed by the BMDMs could be detected for at least 3 days. In atherosclerosis mouse model, atherosclerotic plaques formed in the aortic arches and valves. The radioactive signal of the injected I-oxLDL was detected in atherosclerotic plaques of the aortic arch, and its intensity was positively correlated with the lesion size. Furthermore, the DiI-oxLDL fluorescent signals were detected in foam cells accumulating in atherosclerotic plaques. Thus, we found that I-oxLDL can be used as a radiotracer in the radioimaging of foam cells in atherosclerotic plaques by autoradiography, suggesting its potential future applications in bioimaging methods such as single-photon emission computed tomography.

References
1.
Chen W, Schilperoort M, Cao Y, Shi J, Tabas I, Tao W . Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat Rev Cardiol. 2021; 19(4):228-249. PMC: 8580169. DOI: 10.1038/s41569-021-00629-x. View

2.
Itabe H . Oxidized phospholipids as a new landmark in atherosclerosis. Prog Lipid Res. 1998; 37(2-3):181-207. DOI: 10.1016/s0163-7827(98)00009-5. View

3.
Chistiakov D, Bobryshev Y, Orekhov A . Macrophage-mediated cholesterol handling in atherosclerosis. J Cell Mol Med. 2015; 20(1):17-28. PMC: 4717859. DOI: 10.1111/jcmm.12689. View

4.
Hosomi K, Kawashima H, Nakano A, Kakino A, Okamatsu-Ogura Y, Yamashita Y . NanoSPECT imaging reveals the uptake of 123I-labelled oxidized low-density lipoprotein in the brown adipose tissue of mice via CD36. Cardiovasc Res. 2022; 119(4):1008-1020. DOI: 10.1093/cvr/cvac167. View

5.
Nishigori K, Temma T, Yoda K, Onoe S, Kondo N, Shiomi M . Radioiodinated peptide probe for selective detection of oxidized low density lipoprotein in atherosclerotic plaques. Nucl Med Biol. 2012; 40(1):97-103. DOI: 10.1016/j.nucmedbio.2012.08.002. View